Institutional investors purchased a net $308.5 thousand shares of TEVA during the quarter ended June 2015, and now own 55.37% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ETHENEA INDEPENDENT INVESTORS SA Bought 1.9 Million shares of Teva Pharmaceutical
EATON VANCE MANAGEMENT Bought 603.7 Thousand shares of Teva Pharmaceutical
CAPITAL FUND MANAGEMENT SA Bought 506.5 Thousand shares of Teva Pharmaceutical